Flibanserin is a mixed 5-HT1A agonist and 5-HT2A antagonist for treatment of premenopausal women with hypoactive sexual desire disorder. It is the first FDA-approved treatment for this disorder and can improve the number of satisfying sexual events. The drug has been associated with hypotension and syncope.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/01.JAA.0000532129.61154.3e | DOI Listing |
Publication Analysis
Top Keywords
hypoactive sexual
8
sexual desire
8
desire disorder
8
premenopausal women
8
flibanserin hypoactive
4
disorder premenopausal
4
women flibanserin
4
flibanserin mixed
4
mixed 5-ht1a
4
5-ht1a agonist
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!